Global Mrd Minimal Residual Disease Testing Market Research Report 2026(Status and Outlook)

December 2025 | 166 pages | ID: G8486C6F8D30EN
Bosson Research

Abstracts

Minimal residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. The number of remaining cells may be so small that they do not cause any physical signs or symptoms and often cannot even be detected through traditional methods, such as viewing cells under a microscope and/or by tracking abnormal serum proteins in the blood. An MRD positive test result means that residual (remaining) disease was detected. A negative result means that residual disease was not detected,The most widely used tests to measure MRD are flow cytometry, polymerase chain reaction (PCR) and next-generation sequencing (NGS).

The global Mrd Minimal Residual Disease Testing market size was estimated at USD 1250.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.85% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Mrd Minimal Residual Disease Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Mrd Minimal Residual Disease Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Mrd Minimal Residual Disease Testing market.

Global Mrd Minimal Residual Disease Testing Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company
ICON plc
ArcherDX(Invitae)
ARUP Laboratories
Asuragen
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
LabCorp
Inivata
Natera
NeoGenomics Laboratories
Opko Health
Quest Diagnostics
Sysmex Corporation
Adaptive Biotechnologies

Market Segmentation (by Type)

Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)

Market Segmentation (by Application)

Specialty Clinics and Hospitals
Diagnostic Laboratories
Research Institutions

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Mrd Minimal Residual Disease Testing Market

Overview of the regional outlook of the Mrd Minimal Residual Disease Testing Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Mrd Minimal Residual Disease Testing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Mrd Minimal Residual Disease Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Mrd Minimal Residual Disease Testing
1.2 Key Market Segments
  1.2.1 Mrd Minimal Residual Disease Testing Segment by Type
  1.2.2 Mrd Minimal Residual Disease Testing Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MRD MINIMAL RESIDUAL DISEASE TESTING MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Mrd Minimal Residual Disease Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Mrd Minimal Residual Disease Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MRD MINIMAL RESIDUAL DISEASE TESTING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Mrd Minimal Residual Disease Testing Product Life Cycle
3.3 Global Mrd Minimal Residual Disease Testing Sales by Manufacturers (2020-2025)
3.4 Global Mrd Minimal Residual Disease Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Mrd Minimal Residual Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Mrd Minimal Residual Disease Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Mrd Minimal Residual Disease Testing Market Competitive Situation and Trends
  3.8.1 Mrd Minimal Residual Disease Testing Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Mrd Minimal Residual Disease Testing Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MRD MINIMAL RESIDUAL DISEASE TESTING INDUSTRY CHAIN ANALYSIS

4.1 Mrd Minimal Residual Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MRD MINIMAL RESIDUAL DISEASE TESTING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Mrd Minimal Residual Disease Testing Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Mrd Minimal Residual Disease Testing Market
5.7 ESG Ratings of Leading Companies

6 MRD MINIMAL RESIDUAL DISEASE TESTING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Mrd Minimal Residual Disease Testing Sales Market Share by Type (2020-2025)
6.3 Global Mrd Minimal Residual Disease Testing Market Size by Type (2020-2025)
6.4 Global Mrd Minimal Residual Disease Testing Price by Type (2020-2025)

7 MRD MINIMAL RESIDUAL DISEASE TESTING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Mrd Minimal Residual Disease Testing Market Sales by Application (2020-2025)
7.3 Global Mrd Minimal Residual Disease Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Mrd Minimal Residual Disease Testing Sales Growth Rate by Application (2020-2025)

8 MRD MINIMAL RESIDUAL DISEASE TESTING MARKET SALES BY REGION

8.1 Global Mrd Minimal Residual Disease Testing Sales by Region
  8.1.1 Global Mrd Minimal Residual Disease Testing Sales by Region
  8.1.2 Global Mrd Minimal Residual Disease Testing Sales Market Share by Region
8.2 Global Mrd Minimal Residual Disease Testing Market Size by Region
  8.2.1 Global Mrd Minimal Residual Disease Testing Market Size by Region
  8.2.2 Global Mrd Minimal Residual Disease Testing Market Size by Region
8.3 North America
  8.3.1 North America Mrd Minimal Residual Disease Testing Sales by Country
  8.3.2 North America Mrd Minimal Residual Disease Testing Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Mrd Minimal Residual Disease Testing Sales by Country
  8.4.2 Europe Mrd Minimal Residual Disease Testing Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Mrd Minimal Residual Disease Testing Sales by Region
  8.5.2 Asia Pacific Mrd Minimal Residual Disease Testing Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Mrd Minimal Residual Disease Testing Sales by Country
  8.6.2 South America Mrd Minimal Residual Disease Testing Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Mrd Minimal Residual Disease Testing Sales by Region
  8.7.2 Middle East and Africa Mrd Minimal Residual Disease Testing Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 MRD MINIMAL RESIDUAL DISEASE TESTING MARKET PRODUCTION BY REGION

9.1 Global Production of Mrd Minimal Residual Disease Testing by Region(2020-2025)
9.2 Global Mrd Minimal Residual Disease Testing Revenue Market Share by Region (2020-2025)
9.3 Global Mrd Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Mrd Minimal Residual Disease Testing Production
  9.4.1 North America Mrd Minimal Residual Disease Testing Production Growth Rate (2020-2025)
  9.4.2 North America Mrd Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Mrd Minimal Residual Disease Testing Production
  9.5.1 Europe Mrd Minimal Residual Disease Testing Production Growth Rate (2020-2025)
  9.5.2 Europe Mrd Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Mrd Minimal Residual Disease Testing Production (2020-2025)
  9.6.1 Japan Mrd Minimal Residual Disease Testing Production Growth Rate (2020-2025)
  9.6.2 Japan Mrd Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Mrd Minimal Residual Disease Testing Production (2020-2025)
  9.7.1 China Mrd Minimal Residual Disease Testing Production Growth Rate (2020-2025)
  9.7.2 China Mrd Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 ICON plc
  10.1.1 ICON plc Basic Information
  10.1.2 ICON plc Mrd Minimal Residual Disease Testing Product Overview
  10.1.3 ICON plc Mrd Minimal Residual Disease Testing Product Market Performance
  10.1.4 ICON plc Business Overview
  10.1.5 ICON plc SWOT Analysis
  10.1.6 ICON plc Recent Developments
10.2 ArcherDX(Invitae)
  10.2.1 ArcherDX(Invitae) Basic Information
  10.2.2 ArcherDX(Invitae) Mrd Minimal Residual Disease Testing Product Overview
  10.2.3 ArcherDX(Invitae) Mrd Minimal Residual Disease Testing Product Market Performance
  10.2.4 ArcherDX(Invitae) Business Overview
  10.2.5 ArcherDX(Invitae) SWOT Analysis
  10.2.6 ArcherDX(Invitae) Recent Developments
10.3 ARUP Laboratories
  10.3.1 ARUP Laboratories Basic Information
  10.3.2 ARUP Laboratories Mrd Minimal Residual Disease Testing Product Overview
  10.3.3 ARUP Laboratories Mrd Minimal Residual Disease Testing Product Market Performance
  10.3.4 ARUP Laboratories Business Overview
  10.3.5 ARUP Laboratories SWOT Analysis
  10.3.6 ARUP Laboratories Recent Developments
10.4 Asuragen
  10.4.1 Asuragen Basic Information
  10.4.2 Asuragen Mrd Minimal Residual Disease Testing Product Overview
  10.4.3 Asuragen Mrd Minimal Residual Disease Testing Product Market Performance
  10.4.4 Asuragen Business Overview
  10.4.5 Asuragen Recent Developments
10.5 Cergentis B.V.
  10.5.1 Cergentis B.V. Basic Information
  10.5.2 Cergentis B.V. Mrd Minimal Residual Disease Testing Product Overview
  10.5.3 Cergentis B.V. Mrd Minimal Residual Disease Testing Product Market Performance
  10.5.4 Cergentis B.V. Business Overview
  10.5.5 Cergentis B.V. Recent Developments
10.6 Bio-Rad Laboratories
  10.6.1 Bio-Rad Laboratories Basic Information
  10.6.2 Bio-Rad Laboratories Mrd Minimal Residual Disease Testing Product Overview
  10.6.3 Bio-Rad Laboratories Mrd Minimal Residual Disease Testing Product Market Performance
  10.6.4 Bio-Rad Laboratories Business Overview
  10.6.5 Bio-Rad Laboratories Recent Developments
10.7 Mission Bio
  10.7.1 Mission Bio Basic Information
  10.7.2 Mission Bio Mrd Minimal Residual Disease Testing Product Overview
  10.7.3 Mission Bio Mrd Minimal Residual Disease Testing Product Market Performance
  10.7.4 Mission Bio Business Overview
  10.7.5 Mission Bio Recent Developments
10.8 Guardant Health
  10.8.1 Guardant Health Basic Information
  10.8.2 Guardant Health Mrd Minimal Residual Disease Testing Product Overview
  10.8.3 Guardant Health Mrd Minimal Residual Disease Testing Product Market Performance
  10.8.4 Guardant Health Business Overview
  10.8.5 Guardant Health Recent Developments
10.9 Invivoscribe
  10.9.1 Invivoscribe Basic Information
  10.9.2 Invivoscribe Mrd Minimal Residual Disease Testing Product Overview
  10.9.3 Invivoscribe Mrd Minimal Residual Disease Testing Product Market Performance
  10.9.4 Invivoscribe Business Overview
  10.9.5 Invivoscribe Recent Developments
10.10 LabCorp
  10.10.1 LabCorp Basic Information
  10.10.2 LabCorp Mrd Minimal Residual Disease Testing Product Overview
  10.10.3 LabCorp Mrd Minimal Residual Disease Testing Product Market Performance
  10.10.4 LabCorp Business Overview
  10.10.5 LabCorp Recent Developments
10.11 Inivata
  10.11.1 Inivata Basic Information
  10.11.2 Inivata Mrd Minimal Residual Disease Testing Product Overview
  10.11.3 Inivata Mrd Minimal Residual Disease Testing Product Market Performance
  10.11.4 Inivata Business Overview
  10.11.5 Inivata Recent Developments
10.12 Natera
  10.12.1 Natera Basic Information
  10.12.2 Natera Mrd Minimal Residual Disease Testing Product Overview
  10.12.3 Natera Mrd Minimal Residual Disease Testing Product Market Performance
  10.12.4 Natera Business Overview
  10.12.5 Natera Recent Developments
10.13 NeoGenomics Laboratories
  10.13.1 NeoGenomics Laboratories Basic Information
  10.13.2 NeoGenomics Laboratories Mrd Minimal Residual Disease Testing Product Overview
  10.13.3 NeoGenomics Laboratories Mrd Minimal Residual Disease Testing Product Market Performance
  10.13.4 NeoGenomics Laboratories Business Overview
  10.13.5 NeoGenomics Laboratories Recent Developments
10.14 Opko Health
  10.14.1 Opko Health Basic Information
  10.14.2 Opko Health Mrd Minimal Residual Disease Testing Product Overview
  10.14.3 Opko Health Mrd Minimal Residual Disease Testing Product Market Performance
  10.14.4 Opko Health Business Overview
  10.14.5 Opko Health Recent Developments
10.15 Quest Diagnostics
  10.15.1 Quest Diagnostics Basic Information
  10.15.2 Quest Diagnostics Mrd Minimal Residual Disease Testing Product Overview
  10.15.3 Quest Diagnostics Mrd Minimal Residual Disease Testing Product Market Performance
  10.15.4 Quest Diagnostics Business Overview
  10.15.5 Quest Diagnostics Recent Developments
10.16 Sysmex Corporation
  10.16.1 Sysmex Corporation Basic Information
  10.16.2 Sysmex Corporation Mrd Minimal Residual Disease Testing Product Overview
  10.16.3 Sysmex Corporation Mrd Minimal Residual Disease Testing Product Market Performance
  10.16.4 Sysmex Corporation Business Overview
  10.16.5 Sysmex Corporation Recent Developments
10.17 Adaptive Biotechnologies
  10.17.1 Adaptive Biotechnologies Basic Information
  10.17.2 Adaptive Biotechnologies Mrd Minimal Residual Disease Testing Product Overview
  10.17.3 Adaptive Biotechnologies Mrd Minimal Residual Disease Testing Product Market Performance
  10.17.4 Adaptive Biotechnologies Business Overview
  10.17.5 Adaptive Biotechnologies Recent Developments

11 MRD MINIMAL RESIDUAL DISEASE TESTING MARKET FORECAST BY REGION

11.1 Global Mrd Minimal Residual Disease Testing Market Size Forecast
11.2 Global Mrd Minimal Residual Disease Testing Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Mrd Minimal Residual Disease Testing Market Size Forecast by Country
  11.2.3 Asia Pacific Mrd Minimal Residual Disease Testing Market Size Forecast by Region
  11.2.4 South America Mrd Minimal Residual Disease Testing Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Mrd Minimal Residual Disease Testing by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Mrd Minimal Residual Disease Testing Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Mrd Minimal Residual Disease Testing by Type (2026-2035)
  12.1.2 Global Mrd Minimal Residual Disease Testing Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Mrd Minimal Residual Disease Testing by Type (2026-2035)
12.2 Global Mrd Minimal Residual Disease Testing Market Forecast by Application (2026-2035)
  12.2.1 Global Mrd Minimal Residual Disease Testing Sales (K Units) Forecast by Application
  12.2.2 Global Mrd Minimal Residual Disease Testing Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Mrd Minimal Residual Disease Testing Market Size by Type (M USD)
Table 4. Global Mrd Minimal Residual Disease Testing Market Size by Application
Table 5. Mrd Minimal Residual Disease Testing Market Size Comparison by Region (M USD)
Table 6. Global Mrd Minimal Residual Disease Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Mrd Minimal Residual Disease Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Mrd Minimal Residual Disease Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Mrd Minimal Residual Disease Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mrd Minimal Residual Disease Testing as of 2025)
Table 11. Global Market Mrd Minimal Residual Disease Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Mrd Minimal Residual Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Mrd Minimal Residual Disease Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Mrd Minimal Residual Disease Testing Sales by Type (K Units)
Table 27. Global Mrd Minimal Residual Disease Testing Market Size by Type (M USD)
Table 28. Global Mrd Minimal Residual Disease Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Mrd Minimal Residual Disease Testing Sales Market Share by Type (2020-2025)
Table 30. Global Mrd Minimal Residual Disease Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Mrd Minimal Residual Disease Testing Market Share by Type (2020-2025)
Table 32. Global Mrd Minimal Residual Disease Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Mrd Minimal Residual Disease Testing Sales (K Units) by Application
Table 34. Global Mrd Minimal Residual Disease Testing Market Size by Application
Table 35. Global Mrd Minimal Residual Disease Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Mrd Minimal Residual Disease Testing Sales Market Share by Application (2020-2025)
Table 37. Global Mrd Minimal Residual Disease Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Mrd Minimal Residual Disease Testing Market Share by Application (2020-2025)
Table 39. Global Mrd Minimal Residual Disease Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Mrd Minimal Residual Disease Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Mrd Minimal Residual Disease Testing Sales Market Share by Region (2020-2025)
Table 42. Global Mrd Minimal Residual Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Mrd Minimal Residual Disease Testing Market Size by Region (2020-2025)
Table 44. North America Mrd Minimal Residual Disease Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Mrd Minimal Residual Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Mrd Minimal Residual Disease Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Mrd Minimal Residual Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Mrd Minimal Residual Disease Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Mrd Minimal Residual Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Mrd Minimal Residual Disease Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Mrd Minimal Residual Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Mrd Minimal Residual Disease Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Mrd Minimal Residual Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Mrd Minimal Residual Disease Testing Production (K Units) by Region(2020-2025)
Table 55. Global Mrd Minimal Residual Disease Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Mrd Minimal Residual Disease Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Mrd Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Mrd Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Mrd Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Mrd Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Mrd Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. ICON plc Basic Information
Table 63. ICON plc Mrd Minimal Residual Disease Testing Product Overview
Table 64. ICON plc Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. ICON plc Business Overview
Table 66. ICON plc SWOT Analysis
Table 67. ICON plc Recent Developments
Table 68. ArcherDX(Invitae) Basic Information
Table 69. ArcherDX(Invitae) Mrd Minimal Residual Disease Testing Product Overview
Table 70. ArcherDX(Invitae) Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. ArcherDX(Invitae) Business Overview
Table 72. ArcherDX(Invitae) SWOT Analysis
Table 73. ArcherDX(Invitae) Recent Developments
Table 74. ARUP Laboratories Basic Information
Table 75. ARUP Laboratories Mrd Minimal Residual Disease Testing Product Overview
Table 76. ARUP Laboratories Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. ARUP Laboratories Business Overview
Table 78. ARUP Laboratories SWOT Analysis
Table 79. ARUP Laboratories Recent Developments
Table 80. Asuragen Basic Information
Table 81. Asuragen Mrd Minimal Residual Disease Testing Product Overview
Table 82. Asuragen Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Asuragen Business Overview
Table 84. Asuragen Recent Developments
Table 85. Cergentis B.V. Basic Information
Table 86. Cergentis B.V. Mrd Minimal Residual Disease Testing Product Overview
Table 87. Cergentis B.V. Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Cergentis B.V. Business Overview
Table 89. Cergentis B.V. Recent Developments
Table 90. Bio-Rad Laboratories Basic Information
Table 91. Bio-Rad Laboratories Mrd Minimal Residual Disease Testing Product Overview
Table 92. Bio-Rad Laboratories Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Bio-Rad Laboratories Business Overview
Table 94. Bio-Rad Laboratories Recent Developments
Table 95. Mission Bio Basic Information
Table 96. Mission Bio Mrd Minimal Residual Disease Testing Product Overview
Table 97. Mission Bio Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Mission Bio Business Overview
Table 99. Mission Bio Recent Developments
Table 100. Guardant Health Basic Information
Table 101. Guardant Health Mrd Minimal Residual Disease Testing Product Overview
Table 102. Guardant Health Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Guardant Health Business Overview
Table 104. Guardant Health Recent Developments
Table 105. Invivoscribe Basic Information
Table 106. Invivoscribe Mrd Minimal Residual Disease Testing Product Overview
Table 107. Invivoscribe Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Invivoscribe Business Overview
Table 109. Invivoscribe Recent Developments
Table 110. LabCorp Basic Information
Table 111. LabCorp Mrd Minimal Residual Disease Testing Product Overview
Table 112. LabCorp Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. LabCorp Business Overview
Table 114. LabCorp Recent Developments
Table 115. Inivata Basic Information
Table 116. Inivata Mrd Minimal Residual Disease Testing Product Overview
Table 117. Inivata Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Inivata Business Overview
Table 119. Inivata Recent Developments
Table 120. Natera Basic Information
Table 121. Natera Mrd Minimal Residual Disease Testing Product Overview
Table 122. Natera Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Natera Business Overview
Table 124. Natera Recent Developments
Table 125. NeoGenomics Laboratories Basic Information
Table 126. NeoGenomics Laboratories Mrd Minimal Residual Disease Testing Product Overview
Table 127. NeoGenomics Laboratories Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. NeoGenomics Laboratories Business Overview
Table 129. NeoGenomics Laboratories Recent Developments
Table 130. Opko Health Basic Information
Table 131. Opko Health Mrd Minimal Residual Disease Testing Product Overview
Table 132. Opko Health Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Opko Health Business Overview
Table 134. Opko Health Recent Developments
Table 135. Quest Diagnostics Basic Information
Table 136. Quest Diagnostics Mrd Minimal Residual Disease Testing Product Overview
Table 137. Quest Diagnostics Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Quest Diagnostics Business Overview
Table 139. Quest Diagnostics Recent Developments
Table 140. Sysmex Corporation Basic Information
Table 141. Sysmex Corporation Mrd Minimal Residual Disease Testing Product Overview
Table 142. Sysmex Corporation Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Sysmex Corporation Business Overview
Table 144. Sysmex Corporation Recent Developments
Table 145. Adaptive Biotechnologies Basic Information
Table 146. Adaptive Biotechnologies Mrd Minimal Residual Disease Testing Product Overview
Table 147. Adaptive Biotechnologies Mrd Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Adaptive Biotechnologies Business Overview
Table 149. Adaptive Biotechnologies Recent Developments
Table 150. Global Mrd Minimal Residual Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 151. Global Mrd Minimal Residual Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Mrd Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 153. North America Mrd Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Mrd Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 155. Europe Mrd Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Mrd Minimal Residual Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 157. Asia Pacific Mrd Minimal Residual Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Mrd Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 159. South America Mrd Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Mrd Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Mrd Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Mrd Minimal Residual Disease Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 163. Global Mrd Minimal Residual Disease Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Mrd Minimal Residual Disease Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 165. Global Mrd Minimal Residual Disease Testing Sales (K Units) Forecast by Application (2026-2035)
Table 166. Global Mrd Minimal Residual Disease Testing Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Mrd Minimal Residual Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Mrd Minimal Residual Disease Testing Market Size (M USD), 2025-2035
Figure 5. Global Mrd Minimal Residual Disease Testing Market Size (M USD) (2020-2035)
Figure 6. Global Mrd Minimal Residual Disease Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Mrd Minimal Residual Disease Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Mrd Minimal Residual Disease Testing Product Life Cycle
Figure 13. Mrd Minimal Residual Disease Testing Sales Share by Manufacturers in 2025
Figure 14. Global Mrd Minimal Residual Disease Testing Revenue Share by Manufacturers in 2025
Figure 15. Mrd Minimal Residual Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Mrd Minimal Residual Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Mrd Minimal Residual Disease Testing Revenue in 2025
Figure 18. Industry Chain Map of Mrd Minimal Residual Disease Testing
Figure 19. Global Mrd Minimal Residual Disease Testing Market PEST Analysis
Figure 20. Global Mrd Minimal Residual Disease Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Mrd Minimal Residual Disease Testing Market Share by Type
Figure 27. Sales Market Share of Mrd Minimal Residual Disease Testing by Type (2020-2025)
Figure 28. Sales Market Share of Mrd Minimal Residual Disease Testing by Type in 2025
Figure 29. Market Share of Mrd Minimal Residual Disease Testing by Type (2020-2025)
Figure 30. Market Share of Mrd Minimal Residual Disease Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Mrd Minimal Residual Disease Testing Market Share by Application
Figure 33. Global Mrd Minimal Residual Disease Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Mrd Minimal Residual Disease Testing Sales Market Share by Application in 2025
Figure 35. Global Mrd Minimal Residual Disease Testing Market Share by Application (2020-2025)
Figure 36. Global Mrd Minimal Residual Disease Testing Market Share by Application in 2025
Figure 37. Global Mrd Minimal Residual Disease Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Mrd Minimal Residual Disease Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Mrd Minimal Residual Disease Testing Market Size by Region (2020-2025)
Figure 40. North America Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Mrd Minimal Residual Disease Testing Sales Market Share by Country in 2024
Figure 43. North America Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Mrd Minimal Residual Disease Testing Market Size by Country in 2024
Figure 45. U.S. Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Mrd Minimal Residual Disease Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Mrd Minimal Residual Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Mrd Minimal Residual Disease Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Mrd Minimal Residual Disease Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Mrd Minimal Residual Disease Testing Sales Market Share by Country in 2024
Figure 53. Europe Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Mrd Minimal Residual Disease Testing Market Size by Country in 2024
Figure 55. Germany Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Mrd Minimal Residual Disease Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Mrd Minimal Residual Disease Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Mrd Minimal Residual Disease Testing Market Size by Region in 2024
Figure 68. China Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Mrd Minimal Residual Disease Testing Sales and Growth Rate (K Units)
Figure 79. South America Mrd Minimal Residual Disease Testing Sales Market Share by Country in 2024
Figure 80. South America Mrd Minimal Residual Disease Testing Market Size and Growth Rate (M USD)
Figure 81. South America Mrd Minimal Residual Disease Testing Market Size by Country in 2024
Figure 82. Brazil Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Mrd Minimal Residual Disease Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Mrd Minimal Residual Disease Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Mrd Minimal Residual Disease Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Mrd Minimal Residual Disease Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Mrd Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Mrd Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Mrd Minimal Residual Disease Testing Production Market Share by Region (2020-2025)
Figure 103. North America Mrd Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Mrd Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Mrd Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Mrd Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Mrd Minimal Residual Disease Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Mrd Minimal Residual Disease Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Mrd Minimal Residual Disease Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Mrd Minimal Residual Disease Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Mrd Minimal Residual Disease Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Mrd Minimal Residual Disease Testing Market Share Forecast by Application (2026-2035)